Compounds useful as modulators of TRPM8

US10016418B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10016418-B2
Application numberUS-201615205608-A
CountryUS
Kind codeB2
Filing dateJul 8, 2016
Priority dateNov 5, 2010
Publication dateJul 10, 2018
Grant dateJul 10, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention includes compounds useful as modulators of TRPM8, such as compounds of Formula (I) and the subgenus and species thereof; personal products containing those compounds; and the use of those compounds and the personal products, particularly the use of increasing or inducing chemesthetic sensations, such as cooling or cold sensations.

First claim

Opening claim text (preview).

What is claimed is: 1. A composition comprising a compound having structural Formula (II): or a salt or solvate thereof; wherein Ar is optionally substituted aryl, optionally substituted carbocyclyl, or optionally substituted pyrrolyl, furanyl, thienyl, pyrazolyl, triazolyl, oxazolyl, thiazolyl, isoxazolyl, isothiazolyl, pyridyl, pyrimidyl, or triazinyl; X 1 -X 2 is O—CR 2a R 2b , or CR 5 ═CR 6 ; R 2a , R 2b , R 5 , and R 6 are independently hydrogen or lower alkyl; Y is oxygen or sulfur; Z is nitrogen or CR; n is 0, 1, or 2; R is hydrogen or lower alkyl; R 1 is an optionally substituted group selected from the group consisting of pyrrolyl, furanyl, thienyl, and pyrazolyl; and each R 2 is independently optionally substituted C 1 -C 6 alkyl, optionally substituted C 2 -C 6 alkenyl, C 1 -C 6 alkoxy, hydroxyl, halo, nitro, or cyano, wherein each optional substituent is selected from the group consisting of C 1 -C 6 alkyl, alkenyl, C 1 -C 6 alkoxy, hydroxyl, halo, nitro, or cyano; or two substituents, together with the atoms to which they are attached, form an optionally substituted carbocyclyl or heterocyclyl containing one or more heteroatom(s) selected from nitrogen, oxygen, and sulfur; and a carrier. 2. The composition of claim 1 , wherein Y is sulfur. 3. The composition of claim 1 , Z is nitrogen or CR. 4. The composition of claim 1 , wherein n is 0. 5. The composition of claim 1 , wherein R 1 is an optionally substituted group selected from the group consisting of furanyl, thienyl, and pyrazolyl. 6. A composition comprising a compound, wherein the compound selected from the group consisting of: or a salt or solvate thereof, and a carrier. 7. A composition comprising a compound, wherein the compound selected from the group consisting of: or a salt or solvate thereof, and a carrier. 8. The composition of claim 1 , wherein the compound selected from the group consisting of: or a salt or solvate thereof. 9. The composition of claim 1 , wherein the compound selected from the group consisting of: or a salt or solvate thereof. 10. The composition of claim 1 , wherein the compound selected from the group consisting of: or a salt or solvate thereof. 11. The composition of claim 10 , wherein the composition is an ingestible composition or personal care composition. 12. The composition of claim 11 , wherein the ingestible composition is a food or beverage. 13. The composition of claim 1 , wherein the composition is in form of a solid, semi-solid, plaster, solution, suspension, lotion, cream, foam, gel, paste, emulsion, or a combination thereof. 14. The composition of claim 1 , wherein the compound in the composition is in a concentration ranging from about 0.0001 ppm to 100,000 ppm. 15. The composition of claim 1 , wherein the compound in the composition is in a concentration ranging from about 1 ppm to 500 ppm. 16. The composition of claim 1 , which is a component of a textile product or a packaging material. 17. The composition of claim 1 , wherein the compound is: or a salt or solvate thereof.

Assignees

Inventors

Classifications

  • Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

  • Antineoplastic agents · CPC title

  • Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title

  • Centrally acting analgesics, e.g. opioids · CPC title

  • for peripheral neuropathies · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10016418B2 cover?
The present invention includes compounds useful as modulators of TRPM8, such as compounds of Formula (I) and the subgenus and species thereof; personal products containing those compounds; and the use of those compounds and the personal products, particularly the use of increasing or inducing chemesthetic sensations, such as cooling or cold sensations.
Who is the assignee on this patent?
Senomyx Inc, Seaomyx Inc
What technology area does this patent fall under?
Primary CPC classification C07D231/40. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).